Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Risedronate (35mg) Tablet
Therapeutic Category
Nutraceuticals, Multivitamins and Multiminerals, Orthopedics
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10x4
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Risenet 35 Tablet containing Risedronate is used for the treatment of osteoporosis. It helps in strengthening bones, improving bone density, and reducing the risk of fractures.
Risedronate works by slowing down bone loss and maintaining bone strength by inhibiting osteoclast activity, which helps in preserving bone structure and density.
The tablet is widely prescribed for post-menopausal osteoporosis and bone-related conditions, leading to consistent demand and long-term usage in orthopedic practice.
With increasing cases of bone disorders and aging population, this product offers strong business potential for retailers and distributors. Its long-term therapy requirement, steady prescription demand, and essential role in bone health management make it a reliable product for consistent sales and growth in the orthopedic segment.
Some patients may experience abdominal pain, heartburn, nausea, constipation, or musculoskeletal pain. Rarely, esophageal irritation, jaw problems (osteonecrosis), or atypical fractures may occur with long-term use.
Risenet 35 Tablet is indicated for the treatment and prevention of osteoporosis in postmenopausal women and in men at risk of fractures. It is also used in conditions like glucocorticoid-induced osteoporosis. It helps increase bone strength, reduce bone breakdown, and lower the risk of vertebral and non-vertebral fractures.
This medicine should be used under medical supervision. It should be taken exactly as directed, usually on an empty stomach with water, and the patient should remain upright for at least 30 minutes after intake. Calcium or antacid supplements should not be taken immediately with this medicine.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Composition : Calcium Carbonate (Elemental Calcium) 500mg + Vitamin D3 250 IU Tablet
Composition : Calcitonin 200IU Nasal spray
Composition : Calcium Citrate 750mg + Calcium Aspartate Anhydrous 500mg + Calcium Orotate 100mg + Vitamin D3 500 IU Tablets
Composition : Calcium Citrate Malate (250mg) + Vitamin D3 (100mg) + Folic Acid (50mcg) Tablet
Composition : Calcium Carbonate (1250mg) + Vitamin D3 (250 IU) Tablet
Composition : Coral Calcium 750mg Eq. to Calcium 225mg + Vitamin D3 500 IU Tablets
Composition : Cissus quadrangularis (500mg), Calcium citrate malate (500mg), Calcitriol, Vitamin K2-7 (0.25mcg), Methylcobalamin, Folic acid and Zinc (300mcg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Risenet 35 Tablet, containing Risedronate 35mg, has strong demand in the osteoporosis and bone health segment, making it a profitable product for medical distributors, wholesalers, and pharma franchise partners looking to expand their orthopedics and chronic care portfolio.
Medical distributors and agencies can benefit from the consistent market demand for bisphosphonate medicines used in osteoporosis, bone density loss, and post-menopausal bone health management. Risenet 35 Tablet helps strengthen a comprehensive bone and orthopedic care product portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Risenet 35 Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from attractive business margins, reliable product availability, professional support, and access to a trusted osteoporosis and bone health product range when partnering for Risenet 35 Tablet distribution.
Medical distributors, stockists, and wholesalers interested in Risenet 35 Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.